EDIT
Editas Medicine Inc

17,112
Loading...
Loading...
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
246

Frequently Asked Questions

What is Market Cap of Editas Medicine Inc?
What is the 52-week high for Editas Medicine Inc?
What is the 52-week low for Editas Medicine Inc?
What is Editas Medicine Inc stock price today?
What was Editas Medicine Inc stock price yesterday?
What is the PE ratio of Editas Medicine Inc?
What is the Price-to-Book ratio of Editas Medicine Inc?
What is the 50-day moving average of Editas Medicine Inc?
How many employess does Editas Medicine Inc has?

Latest EDIT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.